- Service Name
IsoPSA Test
- Industry
Healthcare, Diagnostics, Cancer Diagnostics, Blood Testing
- Main Value Proposition
The IsoPSA Test provides a more accurate assessment of prostate cancer risk, helping to make informed decisions about further testing and treatment.
- Description
The IsoPSA Test is a novel blood test developed by Cleveland Diagnostics for the early detection of prostate cancer and assessment of the risk of high-grade disease. It offers a more accurate alternative to traditional PSA tests, significantly reducing unnecessary biopsies.
- Key Features
High sensitivity and specificity compared to traditional PSA tests; Reduces unnecessary prostate biopsies by up to 55%; Utilizes the IsoClear platform for clearer cancer diagnostics; Affordable blood tests that enhance clarity in cancer diagnostics
- Use Cases
The IsoPSA Test is most valuable in scenarios where patients are at risk for prostate cancer and need accurate testing to determine the necessity of further invasive procedures.
- Competitive advantages
Significantly reduces the number of unnecessary biopsies; Higher accuracy in detecting aggressive cancer; Developed on a robust platform that supports a portfolio of affordable tests
- Strengths
The main strengths of the IsoPSA Test include its high accuracy, ability to reduce unnecessary procedures, and the innovative IsoClear platform that supports its development.
- Positioning
The IsoPSA Test positions itself as a leading solution in the cancer diagnostics market, focusing on accuracy and patient safety.
- Audience
The target users include men at risk for prostate cancer, healthcare providers looking for reliable diagnostic tools, and oncologists seeking to improve patient outcomes.
- CTA
Learn More
- Tags
Cancer Detection
Prostate Health
Diagnostic Testing
Biotechnology
- Tagline
Improving cancer decisions
- Tone of Voice
Professional, informative, reassuring
- Differentiation
The IsoPSA Test stands out in the market due to its ability to measure structural differences in proteins, offering a clearer understanding of cancer biomarkers compared to traditional methods.
- Brand Positioning
Cleveland Diagnostics is positioned as an innovative leader in the biotechnology and health diagnostics industry, committed to improving cancer detection and patient care.
- Founded
2013-01-01
- Founders
Arnon Chait
Boris Zaslavsky